JP2017504321A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017504321A5 JP2017504321A5 JP2016541720A JP2016541720A JP2017504321A5 JP 2017504321 A5 JP2017504321 A5 JP 2017504321A5 JP 2016541720 A JP2016541720 A JP 2016541720A JP 2016541720 A JP2016541720 A JP 2016541720A JP 2017504321 A5 JP2017504321 A5 JP 2017504321A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- chain variable
- variable region
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461927819P | 2014-01-15 | 2014-01-15 | |
| US61/927,819 | 2014-01-15 | ||
| PCT/US2015/011391 WO2015108967A2 (en) | 2014-01-15 | 2015-01-14 | Rsv-specific antibodies and functional parts thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020020602A Division JP2020103293A (ja) | 2014-01-15 | 2020-02-10 | Ｒｓｖ特異的抗体およびその機能的部分 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017504321A JP2017504321A (ja) | 2017-02-09 |
| JP2017504321A5 true JP2017504321A5 (https=) | 2018-02-22 |
| JP6836398B2 JP6836398B2 (ja) | 2021-03-03 |
Family
ID=53543612
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016541720A Active JP6836398B2 (ja) | 2014-01-15 | 2015-01-14 | Ｒｓｖ特異的抗体およびその機能的部分 |
| JP2020020602A Pending JP2020103293A (ja) | 2014-01-15 | 2020-02-10 | Ｒｓｖ特異的抗体およびその機能的部分 |
| JP2023010903A Pending JP2023052693A (ja) | 2014-01-15 | 2023-01-27 | Ｒｓｖ特異的抗体およびその機能的部分 |
| JP2025003702A Pending JP2025063143A (ja) | 2014-01-15 | 2025-01-09 | Ｒｓｖ特異的抗体およびその機能的部分 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020020602A Pending JP2020103293A (ja) | 2014-01-15 | 2020-02-10 | Ｒｓｖ特異的抗体およびその機能的部分 |
| JP2023010903A Pending JP2023052693A (ja) | 2014-01-15 | 2023-01-27 | Ｒｓｖ特異的抗体およびその機能的部分 |
| JP2025003702A Pending JP2025063143A (ja) | 2014-01-15 | 2025-01-09 | Ｒｓｖ特異的抗体およびその機能的部分 |
Country Status (26)
| Country | Link |
|---|---|
| US (6) | US20160340414A1 (https=) |
| EP (3) | EP3741390A1 (https=) |
| JP (4) | JP6836398B2 (https=) |
| KR (1) | KR102188437B1 (https=) |
| CN (2) | CN116355080A (https=) |
| AU (4) | AU2015206570A1 (https=) |
| CA (1) | CA2933200C (https=) |
| CY (2) | CY1123425T1 (https=) |
| DK (1) | DK3094353T3 (https=) |
| ES (1) | ES2795727T3 (https=) |
| FI (1) | FIC20230016I1 (https=) |
| FR (1) | FR23C1016I1 (https=) |
| HR (1) | HRP20200607T1 (https=) |
| HU (2) | HUE048855T2 (https=) |
| LT (2) | LT3094353T (https=) |
| LU (1) | LUC00305I2 (https=) |
| MX (1) | MX374517B (https=) |
| NL (1) | NL301228I2 (https=) |
| NO (1) | NO2023016I1 (https=) |
| PL (1) | PL3094353T3 (https=) |
| PT (1) | PT3094353T (https=) |
| RS (1) | RS60387B1 (https=) |
| SI (1) | SI3094353T1 (https=) |
| SM (1) | SMT202000282T1 (https=) |
| TW (1) | TWI705974B (https=) |
| WO (1) | WO2015108967A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1997830A1 (en) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
| ES2795727T3 (es) | 2014-01-15 | 2020-11-24 | Medimmune Llc | Anticuerpos específicos del vrs y partes funcionales de los mismos |
| US11479600B2 (en) | 2016-10-21 | 2022-10-25 | Adimab, Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| TWI761453B (zh) * | 2017-03-01 | 2022-04-21 | 英商梅迪繆思有限公司 | 抗rsv單株抗體配製物 |
| KR20200140799A (ko) * | 2018-01-31 | 2020-12-16 | 더 위스타 인스티튜트 오브 아나토미 앤드 바이올로지 | 호흡기 세포융합 바이러스에 대하여 사용하기 위한 핵산 항체 작제물 |
| CN111606993B (zh) * | 2019-02-26 | 2022-06-28 | 中国科学院上海生命科学研究院 | 抗呼吸道合胞病毒的全人广谱中和抗体4f1及其应用 |
| US12024553B2 (en) | 2019-04-30 | 2024-07-02 | Medimmune Limited | Dosage regimens for and compositions including anti-RSV antibodies |
| CA3229901A1 (en) | 2021-09-13 | 2023-03-16 | Medimmune Limited | Prevention of respiratory syncytial virus lower respiratory tract infection with nirsevimab |
| CN119264248A (zh) * | 2022-07-22 | 2025-01-07 | 北京智仁美博生物科技有限公司 | 抗呼吸道合胞病毒中和性抗体及其用途 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| US5892019A (en) | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
| US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| WO2006050166A2 (en) * | 2004-10-29 | 2006-05-11 | Medimmune, Inc. | Methods of preventing and treating rsv infections and related conditions |
| AU2005335714B2 (en) * | 2004-11-10 | 2012-07-26 | Macrogenics, Inc. | Engineering Fc antibody regions to confer effector function |
| MX2009003306A (es) | 2006-10-02 | 2009-04-23 | Medarex Inc | Anticuerpos humanos que se unen a cxcr4 y sus usos. |
| JP2010534057A (ja) * | 2007-03-06 | 2010-11-04 | シムフォゲン・アクティーゼルスカブ | 呼吸器合胞体ウイルス感染症を治療するための組換え抗体 |
| EP1997830A1 (en) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
| US20110008329A1 (en) * | 2007-06-26 | 2011-01-13 | Medlmmune, Llc | Methods of Treating RSV Infections And Related Conditions |
| US8092804B2 (en) * | 2007-12-21 | 2012-01-10 | Medimmune Limited | Binding members for interleukin-4 receptor alpha (IL-4Rα)-173 |
| TWI478937B (zh) | 2008-01-15 | 2015-04-01 | Abbvie Inc | 改良之哺乳動物表現載體及其用途 |
| US9273118B2 (en) * | 2009-07-15 | 2016-03-01 | Aimm Therapeutics B.V. | Means and methods for producing high affinity antibodies |
| JP5762408B2 (ja) * | 2009-08-13 | 2015-08-12 | クルセル ホランド ベー ヴェー | ヒト呼吸器合胞体ウイルス（ｒｓｖ）に対する抗体および使用方法 |
| US8568726B2 (en) | 2009-10-06 | 2013-10-29 | Medimmune Limited | RSV specific binding molecule |
| EP2486053B1 (en) * | 2009-10-06 | 2017-01-18 | Medimmune Limited | Rsv-specific binding molecule |
| US20120263715A1 (en) | 2009-10-28 | 2012-10-18 | Medimmune, Llc | Topical Methods Of Treating RSV Infections And Related Conditions |
| BR112012031638B1 (pt) * | 2010-07-09 | 2021-01-12 | Janssen Vaccines & Prevention B.V. | anticorpo anti-rsv ou fragmento de ligação de antígeno do mesmo, anticorpo multivalente, composição farmacêutica, uso de anticorpo ou fragmento de ligação de antígeno, método de detectar infecção por rsv, e, ácido nucleico isolado |
| CA2867444C (en) * | 2012-03-16 | 2021-04-13 | University Health Network | Compositions containing soluble toso protein and uses thereof |
| US20150158942A1 (en) * | 2012-05-22 | 2015-06-11 | Shire Human Genetic Therapies, Inc. | Anti-ccl2 antibodies for treatment of scleroderma |
| CA2900110A1 (en) | 2013-02-01 | 2014-08-07 | Medimmune, Llc | Respiratory syncytial virus f protein epitopes |
| ES2795727T3 (es) * | 2014-01-15 | 2020-11-24 | Medimmune Llc | Anticuerpos específicos del vrs y partes funcionales de los mismos |
| TWI761453B (zh) | 2017-03-01 | 2022-04-21 | 英商梅迪繆思有限公司 | 抗rsv單株抗體配製物 |
| BR112019018022A2 (pt) | 2017-03-01 | 2020-06-02 | Medimmune Limited | Formulações de anticorpos monoclonais |
-
2015
- 2015-01-14 ES ES15737068T patent/ES2795727T3/es active Active
- 2015-01-14 AU AU2015206570A patent/AU2015206570A1/en not_active Abandoned
- 2015-01-14 KR KR1020167020393A patent/KR102188437B1/ko active Active
- 2015-01-14 PL PL15737068T patent/PL3094353T3/pl unknown
- 2015-01-14 PT PT157370685T patent/PT3094353T/pt unknown
- 2015-01-14 EP EP20161884.0A patent/EP3741390A1/en not_active Withdrawn
- 2015-01-14 HU HUE15737068A patent/HUE048855T2/hu unknown
- 2015-01-14 CA CA2933200A patent/CA2933200C/en active Active
- 2015-01-14 EP EP15737068.5A patent/EP3094353B1/en active Active
- 2015-01-14 US US15/111,610 patent/US20160340414A1/en not_active Abandoned
- 2015-01-14 EP EP23215838.6A patent/EP4353316A3/en active Pending
- 2015-01-14 SI SI201531183T patent/SI3094353T1/sl unknown
- 2015-01-14 HR HRP20200607TT patent/HRP20200607T1/hr unknown
- 2015-01-14 CN CN202211184987.8A patent/CN116355080A/zh active Pending
- 2015-01-14 DK DK15737068.5T patent/DK3094353T3/da active
- 2015-01-14 RS RS20200640A patent/RS60387B1/sr unknown
- 2015-01-14 SM SM20200282T patent/SMT202000282T1/it unknown
- 2015-01-14 JP JP2016541720A patent/JP6836398B2/ja active Active
- 2015-01-14 LT LTEP15737068.5T patent/LT3094353T/lt unknown
- 2015-01-14 CN CN201580003410.4A patent/CN105916520A/zh active Pending
- 2015-01-14 MX MX2016008639A patent/MX374517B/es active IP Right Grant
- 2015-01-14 WO PCT/US2015/011391 patent/WO2015108967A2/en not_active Ceased
- 2015-01-15 TW TW104101373A patent/TWI705974B/zh active
-
2018
- 2018-06-08 US US16/003,455 patent/US10689437B2/en active Active
-
2020
- 2020-02-10 JP JP2020020602A patent/JP2020103293A/ja active Pending
- 2020-05-01 US US16/864,454 patent/US11186628B2/en active Active
- 2020-06-05 CY CY20201100509T patent/CY1123425T1/el unknown
- 2020-06-10 AU AU2020203831A patent/AU2020203831A1/en not_active Abandoned
-
2021
- 2021-06-25 AU AU2021204339A patent/AU2021204339B2/en active Active
- 2021-10-22 US US17/451,955 patent/US11661449B2/en active Active
-
2023
- 2023-01-27 JP JP2023010903A patent/JP2023052693A/ja active Pending
- 2023-04-18 US US18/302,400 patent/US12173050B2/en active Active
- 2023-04-25 NO NO2023016C patent/NO2023016I1/no unknown
- 2023-04-25 FR FR23C1016C patent/FR23C1016I1/fr active Active
- 2023-04-25 CY CY2023011C patent/CY2023011I2/el unknown
- 2023-04-26 NL NL301228C patent/NL301228I2/nl unknown
- 2023-04-26 FI FIC20230016C patent/FIC20230016I1/fi unknown
- 2023-04-27 LU LU00305C patent/LUC00305I2/fr unknown
- 2023-04-28 LT LTPA2023514C patent/LTC3094353I2/lt unknown
- 2023-05-02 HU HUS2300019C patent/HUS2300019I1/hu unknown
-
2024
- 2024-11-11 US US18/943,007 patent/US20250179153A1/en active Pending
-
2025
- 2025-01-09 JP JP2025003702A patent/JP2025063143A/ja active Pending
- 2025-02-14 AU AU2025201056A patent/AU2025201056A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017504321A5 (https=) | ||
| JP2021503455A5 (https=) | ||
| JP2010536384A5 (https=) | ||
| JP2019535763A5 (https=) | ||
| EA202091590A1 (ru) | Антитела против pd-l1 и варианты их применения | |
| JP2011509245A5 (https=) | ||
| JP2018521638A5 (https=) | ||
| RU2018133708A (ru) | Антитела, обладающие специфичностью к btla, и их использование | |
| RU2016100892A (ru) | Антитела против tweakr и их применение | |
| JP2018527919A5 (https=) | ||
| JP2016529882A5 (https=) | ||
| JP2016529229A5 (https=) | ||
| JP2017522903A5 (https=) | ||
| JP2018535650A5 (https=) | ||
| JP2018537421A5 (https=) | ||
| JP2017531642A5 (https=) | ||
| JP2018517431A5 (https=) | ||
| JP2014533239A5 (https=) | ||
| JP2017522043A5 (https=) | ||
| JP2017529097A5 (https=) | ||
| JP2013538057A5 (https=) | ||
| JP2012525829A5 (https=) | ||
| HRP20190714T1 (hr) | Neutralizirajuća protutijela anti-influenca a virusa i njihova uporaba | |
| JP2011528901A5 (https=) | ||
| JP2020500510A5 (https=) |